Pitanium Limited
PTNMPitanium Limited's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is between stages. Underneath, the last four quarters read deteriorating — profit −300.0% year on year, and 50% of the last 2 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Pitanium Limited trades at $10.4, between stages. It sits at 100% of a 52-week range of $1 to $10. On relative strength it has no relative-strength read yet.
Today the stock is between stages. At $10.4 it trades near its long-run average and sits at 100% of its 52-week range ($1–$10).
Against the market, two honest reads. Cumulative: over the last 4 months the stock moved +85% while the S&P 500 moved +12% — ahead of the index over the full window. Recent form: no trailing-13-week read yet — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: how the P/E reads against its own history.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
P/E does not price Pitanium Limited — earnings are negative, so there is no multiple to rank against its own history. The revenue and margin lines below are where a turn, when it comes, would show first. A P/E returns here the first period the bottom line turns positive.
With earnings negative, P/E does not price — there is no multiple to rank against its own history. The revenue and margin lines below are where the turn, when it comes, will show first.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Pitanium Limited reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +0.0% | — | — | — |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
No sector-relative score — Pitanium Limited is not among the largest members shown in this industry comparison for Household & Personal Products.
The score is a rank WITHIN a peer set: every metric is scored by percentile against the other members. Without the peer set there is no score to state, so none is invented here.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Pitanium Limited reported $0.0 B of revenue in the Sep 25 quarter, −25.0% year on year. Over 2 years it has compounded at 0.0% a year. The last full year, FY25, came in at $0.1 B. The last four reported quarters add to $0.1 B.
Pitanium Limited reported $0.0 B of revenue in the Sep 25 quarter, −25.0% year on year. Over 2 years it has compounded at 0.0% a year. The last full year, FY25, came in at $0.1 B. The last four reported quarters add to $0.1 B.
FY25 revenue came in at $0.1 B (+0.0% on the year), capping 2 years at 0.0% compound. The latest quarter (Sep 25) printed $0.0 B, −25.0% year on year.
Pace check: the last four quarters averaged −12.5% growth against the decade's 0.0% — the current year is running slower than its own long-run rate.
→ Revenue slipped — did margins hold as it scaled? Next: −66.7% this quarter (−91.7 pp YoY).
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Pitanium Limited's operating margin is −66.7% in the Sep 25 quarter, −91.7 percentage points against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged −28.6% to 14.3%. The current quarter is running below every full year in that window.
Pitanium Limited's operating margin is −66.7% in the Sep 25 quarter, −91.7 percentage points against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged −28.6% to 14.3%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is −66.7%, −91.7 pp against the same quarter a year ago. Across 3 fiscal years the operating margin has ranged −28.6%–14.3%.
Why: the numbers show the operating margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
→ Margins slipped — did that reach the bottom line? Next: profit −300.0% in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Pitanium Limited posted a net loss of $0.02 B in the Sep 25 quarter. The full FY25 year was a loss of $0.02 B. That loss is 66.7% of the quarter's revenue.
Pitanium Limited posted a net loss of $0.02 B in the Sep 25 quarter. The full FY25 year was a loss of $0.02 B. That loss is 66.7% of the quarter's revenue.
Sep 25 profit was $−0.0 B, −300.0% year on year. On the full year, FY25 printed $−0.0 B (−300.0%).
→ Profit rose — but did the cash follow? Next: 50% of the last 2 years' profit arrived as cash.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 2 fiscal years 50% of Pitanium Limited's reported profit arrived as operating cash — a gap worth watching. In FY25 that was $−0.0 B of operating cash against $−0.0 B of profit. After $0.0 B of capital spending, $−0.0 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY25: operating cash of $−0.0 B against reported profit of $−0.0 B, leaving free cash of $−0.0 B after $0.0 B of capital spending. Across the last 2 fiscal years the conversion rate is 50% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
→ So follow the cash to where it goes. Next: $0.0 B of building over 3 years.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Pitanium Limited does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
→ Does all this activity actually earn its cost of capital? Next: ROE is −81%.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Pitanium Limited earns a ROE of −50% in FY25. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is −28.6% net margin on 1.17× asset turns.
FY25 ROE is −50%.
Why the return is what it is — the wiring (FY25): −28.6% net margin × 1.17× asset turns × 1.50× balance-sheet leverage ≈ −50.2% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.32.
Dividend
Pitanium Limited pays no dividend. Across the last 4 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Pitanium Limited does not currently pay a dividend. Across the last 4 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
→ No payout to follow. The cash question becomes what the business does with what it earns instead.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Debt-to-equity is 0.32 at the latest reading — modestly levered; a full borrowings history is not in our numbers.
We hold only the latest reading here: a debt-to-equity of 0.32 — a modest level of leverage behind the returns above. A year-by-year borrowings ladder is not in our numbers for this stock, so we say that rather than draw a chart we cannot support.
→ Who owns this, and are they adding or leaving? Next: the register.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
No ownership or positioning reading is held for Pitanium Limited, so this section names the gap rather than filling it. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
We hold no ownership or positioning reading for this stock, so this section says that plainly.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Pitanium Limited: the Z-score reads 27.60. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 27.60 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 27.60.
| Company | P/E | Mkt cap | Revenue | EPS | ROCE | Stage |
|---|---|---|---|---|---|---|
| Pitanium Limited this page | — | $0B | — | — | — | No read |
| The Procter & Gamble Company | 21.8× | $347B | Consistent | |||
| Unilever PLC | 13.5× | $143B | No read | |||
| Colgate-Palmolive Company | 36.0× | $74B | Mixed | |||
| Kenvue Inc. | 23.5× | $38B | Improving | |||
| Kimberly-Clark Corporation | 17.8× | $38B | Deteriorating | |||
| The Estée Lauder Companies Inc. | — | $31B | Deteriorating | |||
| Church & Dwight Co., Inc. | 32.9× | $24B | Mixed | |||
| The Clorox Company | 16.3× | $12B | Mixed | |||
| e.l.f. Beauty, Inc. | 191.1× | $5B | Deteriorating | |||
| Interparfums, Inc. | 24.2× | $4B | Topping out | |||
| Coty Inc. | — | $2B | Deteriorating | |||
| Newell Brands Inc. | — | $2B | No read | |||
| Spectrum Brands Holdings, Inc. | 17.3× | $2B | Turning around | |||
| Edgewell Personal Care Company | — | $1B | Deteriorating | |||
| Oddity Tech Ltd. | 20.1× | $1B | Topping out | |||
| Helen of Troy Limited | — | $1B | Turning around | |||
| Magnera Corporation | — | $1B | No read | |||
| The Honest Company, Inc. | — | $0B | No read | |||
| Yatsen Holding Limited | — | $0B | No read | |||
| Nu Skin Enterprises, Inc. | 4.8× | $0B | No read | |||
| Acme United Corporation | 25.0× | $0B | Deteriorating |
Frequently asked questions
What is Pitanium Limited's stock price today?
Pitanium Limited trades at $10.4. The company is valued at $0.0 B. The stock sits at 100% of its 52-week range of $1–$10. — as of 29 July 2026.
What were Pitanium Limited's latest quarterly results?
Pitanium Limited reported revenue of $0.0 B and a net loss of $0.0 B for the Sep 25 quarter. Revenue fell 25.0% and profit fell 300.0% year on year. Earnings per share were $−0.91. The operating margin was −66.7%, 91.7 pp lower than a year earlier. — as of 29 July 2026.
What is Pitanium Limited's revenue?
Pitanium Limited reported revenue of $0.0 B in the Sep 25 quarter, −25.0% year on year. For the full FY25 fiscal year, revenue was $0.1 B (+0.0%). Over the last 2 years revenue compounded at 0.0% a year. — as of 29 July 2026.
What is Pitanium Limited's profit?
Pitanium Limited earned $−0.0 B of net profit in the Sep 25 quarter, −300.0% year on year. Full-year FY25 profit was $−0.0 B. The operating margin ran −66.7% in the latest quarter. — as of 29 July 2026.
What is Pitanium Limited's market cap?
Pitanium Limited's market capitalisation is $0.0 B at a stock price of $10.4. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 29 July 2026.
Does Pitanium Limited pay a dividend?
No — Pitanium Limited has declared no dividend per share in any of its last 4 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 29 July 2026.
Is Pitanium Limited growing?
Not right now — Pitanium Limited's latest numbers are shrinking: latest-quarter revenue −25.0% year on year, profit −300.0%, and the margin −91.7 pp at −66.7%. The earnings engine currently reads: deteriorating — as of 29 July 2026.
How is Pitanium Limited performing?
Pitanium Limited's latest readings are below. Its latest quarter's revenue fell 25.0% and profit fell 300.0% year on year. This describes what the data did, not a rating. — as of 29 July 2026.
Will Pitanium Limited's stock price go up?
This page publishes no price forecast for Pitanium Limited. What it measures instead: the stock price is $10.4. Direction is not something this site claims to know. — as of 29 July 2026.
Does Pitanium Limited have too much debt?
It is moderate — Pitanium Limited's debt-to-equity is 0.32. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 29 July 2026.
What is Pitanium Limited's capex?
Pitanium Limited spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 29 July 2026.
What is Pitanium Limited's cash flow?
Pitanium Limited generated $−0.0 B of operating cash flow in FY25 and $−0.0 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $−0.0 B, so operating cash ran behind profit. — as of 29 July 2026.
Is Pitanium Limited's profit real cash?
Not fully — over the last 2 fiscal years, 50% of Pitanium Limited's reported profit arrived as operating cash. In FY25, operating cash was $−0.0 B against reported profit of $−0.0 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 29 July 2026.
How financially safe is Pitanium Limited?
On the balance sheet, the Z-score reads 27.60 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 29 July 2026.
Where is Pitanium Limited in its business cycle?
Pitanium Limited's FY25 operating margin was −28.6%, against a 3-year band of −28.6%–14.3%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran −66.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 29 July 2026.
What could break the Pitanium Limited story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 29 July 2026.
Is Pitanium Limited a stock worth studying right now?
This is not investment advice. The machine read: Pitanium Limited's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 29 July 2026.